Fitzpatricks Derm8e Ref Ch105

7/30/2019 Fitzpatricks Derm8e Ref Ch105

1/6

Chapter 105CutaneousManifestations of

Drug AbuseHaley Naik & Richard Allen Johnson

REFERENCES

1.American Psychiatric Association: Diagnostic and

Statistical Manual of Mental Disorders IV-TR, 4th

edition. Washington DC, American Psychiatric

Press, 2000

2.Abuse NIoD: 2010, http://www.drugabuse.gov,

accessed Jun 15, 2010

3. Nations U: World Drug Report, 2004, http://www.

unis.unvienna.org/unis/pressrels/2004/unis-

nar849.html, accessed Apr 1, 2010

4.Services USDoHaH: National Survey on Drug Use

and Health, 2008, http://www.oas.samhsa.gov/

NSDUHlatest.htm, accessed Apr 1, 2010

5. Tsuang MT et al: The harvard twin study of

substance abuse: What we have learned. Harv Rev

Psychiatry9(6):267-279, 2001

6. Bibb JA et al: Eects of chronic exposure to co-

caine are regulated by the neuronal protein Cdk5.

Nature410(6826):376-380, 2001

7. Kalivas PW, Volkow ND: The neural basis of addic-

tion: A pathology of motivation and choice.Am J

Psychiatry162(8):1403-1413, 2005

8. Michigan UO. Monitoring the Future, 2010, http://

www.monitoringthefuture.org/, accessed Jun 10,

2010

9. Konzen JP, Levine SR, Garcia JH: Vasospasm and

thrombus formation as possible mechanisms

of stroke related to alkaloidal cocaine. Stroke

26(6):1114-1118, 1995

10. Lange RA, Hillis LD: Cardiovascular complications

of cocaine use. N Engl J Med345(5):351-358, 2001

11. Merkel PA et al: Cocaine-associated cerebral vas-

culitis. Semin Arthritis Rheum25(3):172-183, 1995

12. Moliterno DJ et al: Inuence of intranasal cocaine

on plasma constituents associated with endog-

enous thrombosis and thrombolysis.Am J Med

96(6):492-496, 1994

13. Muniz AE, Evans T: Acute gastrointestinal manifes-

tations associated with use of crack. Am J Emerg

Med19(1):61-63, 2001

14. Strickland TL et al: Cerebral perfusion and neuro-

psychological consequences of chronic cocaine

use.J Neuropsychiatry Clin Neurosci5(4):419-427,

1993

15. Vongpatanasin W et al: Cocaine stimulates the

human cardiovascular system via a central

mechanism of action. Circulation100(5):497-502,

1999

16. Cregler LL, Mark H: Medical complications of

cocaine abuse. N Engl J Med315(23):1495-1500,

1986

17. Goldfrank LR, Homan RS: The cardiovascular

eects of cocaine.Ann Emerg Med20(2):165-175,

1991

18. Spivey WH, Euerle B: Neurologic complications of

cocaine abuse.Ann Emerg Med19(12):1422-1428,

1990

19. Hoeger PH, Haupt G, Hoelzle E: Acute multifo-

cal skin necrosis: Synergism between invasive

streptococcal infection and cocaine-induced tis-

sue ischaemia?Acta Derm Venereol76(3):239-241,

1996

20. Abidin MR et al: Injection of illicit drugs into the

granulation tissue of chronic ulcers.Ann Plast

Surg24(3):268-270, 1990

21. Kircik LH, Wirth P, Pincus SH: Scars on the legs.

Cutaneous brosis resulting from intracutaneous

injection of cocaine.Arch Dermatol128(12):1644,

1647, 1992

22. Feeney CM, Briggs S: Crack hands: A dermatologic

eect of smoking crack cocaine. Cutis50(3):193-

194, 1992

23. Payne-James JJ, Munro MH, Rowland Payne

CM: Pseudosclerodermatous triad of perniosis,

pulp atrophy and parrot-beaked clawing of the

nailsA newly recognized syndrome of chronic

crack cocaine use.J Forensic Leg Med14

(2):65-71,2007

24. Woodburn KR, Murie JA: Vascular complications

of injecting drug misuse. Br J Surg83(10):1329-

1334, 1996

25. Maxwell TM, Olcott CT, Blaisdell FW: Vascu-

lar complications of drug abuse. Arch Surg

105(6):875-882, 1972


2/6

608 Chapter 105: Cutaneous Manifestations of Drug Abuse

Copyright McGraw-Hill Companies, Inc. All rights reserved.

26. Saleem TM, et al: Renal infarction: A rare com-

plication of cocaine abuse.Am J Emerg Med

19(6):528-529, 2001

27. Novielli KD, Chambers CV: Splenic infarction after

cocaine use.Ann Intern Med114(3):251-252, 1991

28. Bellows CF, Raafat AM: The surgical abdomen

associated with cocaine abuse.J Emerg Med23(4):383-386, 2002

29. Ellis CN, McAlexander WW: Enterocolitis as-

sociated with cocaine use. Dis Colon Rectum

48(12):2313-2316, 2005

30. Friedman DR, Wolfsthal SD: Cocaine-induced

pseudovasculitis. Mayo Clin Proc80(5):671-673,

2005

31. Hofbauer GF, Hafner J, Trueb RM: Urticarial

vasculitis following cocaine use. Br J Dermatol

141(3):600-601, 1999

32. Orriols R et al: Cocaine-induced Churg-Strauss

vasculitis. Eur Respir J9(1):175-177, 1996

33. Balbir-Gurman A, Braun-Moscovici Y, Nahir

AM: Cocaine-Induced raynauds phenomenon

and ischaemic nger necrosis. Clin Rheumatol

20(5):376-378, 2001

34. Noel B: Cocaine and arsenic-induced Raynauds

phenomenon. Clin Rheumatol21(4):343-344,

2002

35. Brust JC: Vasculitis owing to substance abuse.

Neurol Clin15(4):945-957, 1997

36. Chevalier X et al: Schoenlein-Henoch purpura

with necrotizing vasculitis after cocaine snorting.

Clin Nephrol43(5):348-349, 1995

37. Bozkurt AK: The role of cocaine in the etiology of

Buerger disease is questionable.Arch Intern Med

161(3):486, 2001

38. Marder VJ, Mellingho IK: Cocaine and Buerger

disease: Is there a pathogenetic association?Arch

Intern Med160(13):2057-2060, 2000

39. Rhodes T, et al: Crack-heroin speedball injection

and its implications for vein care: Qualitative

study.Addiction102(11):1782-1790, 2007

40. Ciccarone D, Bourgois P: Explaining the geo-

graphical variation of HIV among injection drug

users in the United States. Subst Use Misuse38(14):2049-2063, 2003

41. Tyndall MW et al: Intensive injection cocaine use

as the primary risk factor in the Vancouver HIV-1

epidemic. AIDS17(6):887-893, 2003

42. Blanksma CJ, Brand HS: Cocaine abuse: Orofacial

manifestations and implications for dental treat-

ment. Int Dent J55(6):365-369, 2005

43. Kapila YL, Kashani H: Cocaine-associated rapid

gingival recession and dental erosion. A case

report.J Periodontol68(5):485-488, 1997

44. Faruque S, et al: Crack cocaine smoking and oral

sores in three inner-city neighborhoods.J Acquir

Immune Dec Syndr Hum Retrovirol13(1):87-92,

1996

45. Sastry RC, Lee D, Har-El G: Palate perforation

from cocaine abuse. Otolaryngol Head Neck Surg

116(4):565-566, 1997

46. Mattson-Gates G, Jabs AD, Hugo NE: Perforation

of the hard palate associated with cocaine abuse.

Ann Plast Surg26(5):466-468, 1991

47. Mari A, et al: Nasal cocaine abuse and centrofacial

destructive process: Report of three cases includ-

ing treatment. Oral Surg Oral Med Oral Pathol Oral

Radiol Endod93(4):435-439, 2002

48. Deutsch HL, Millard DR Jr: A new cocaine abuse

complex. Involvement of nose, septum, palate,

and pharynx.Arch Otolaryngol Head Neck Surg

115(2):235-237, 1989

49. Villa PD: Midfacial complications of prolonged

cocaine snorting.J Can Dent Assoc65(4):218-223,

1999

50. Osborne R, et al: Adult supraglottitis subsequent

to smoking crack cocaine. Ear Nose Throat J

82(1):53-55, 2003

51. Sachs R, Zagelbaum BM, Hersh PS: Corneal

complications associated with the use of crack

cocaine. Ophthalmology100(2):187-191, 1993

52.

Schwartz RH, et al: Nasal symptoms associatedwith cocaine abuse during adolescence.Arch

Otolaryngol Head Neck Surg115(1):63-64, 1989

53. Snyderman C et al: Crack cocaine burns of the lar-

ynx.Arch Otolaryngol Head Neck Surg117(7):792-

795, 1991

54. Lu LK, High WA: Acute generalized exanthema-

tous pustulosis caused by illicit street drugs?Arch

Dermatol143(3):430-431, 2007

55. Hofbauer GF, Burg G, Nestle FO: Cocaine-related

Stevens-Johnson syndrome. Dermatology

201(3):258-260, 2000

56.Wolgin DL, Hertz JM: Eects of acute and chroniccocaine on milk intake, body weight, and activity

in bottle- and cannula-fed rats. Behav Pharmacol

6(7):746-753, 1995

57. Brady KT et al: Cocaine-induced psychosis.J Clin

Psychiatry52(12):509-512, 1991

58. Zhu NY, Legatt DF, Turner AR: Agranulocytosis

after consumption of cocaine adulterated with

levamisole.Ann Intern Med150(4):287-289, 2009


3/6

Chapter 105: Cutaneous Manifestations of Drug Abuse 609


59. Kinzie E. Levamisole found in patients using

cocaine.Ann Emerg Med53(4):546-547, 2009

60. Darke S, Ross J, Kaye S: Physical injecting sites

among injecting drug users in Sydney, Australia.

Drug Alcohol Depend62(1):77-82, 2001

61. Rathod NH, de Alarcon R, Thomson IG: Signs of

heroin usage detected by drug users and theirparents. Lancet2(7531):1411-1414, 1967

62. Young AW Jr, Rosenberg FR: Cutaneous stigmas

of heroin addiction.Arch Dermatol104(1):80-86,

1971

63. Shuster MM, Lewin ML: Needle tracks in narcotic

addicts. N Y State J Med68(24):3129-3134, 1968

64. Redmond WJ. Heroin adulterants and skin dis-

ease.Arch Dermatol115(1):111, 1979

65. Neviaser RJ, Buttereld WC, Wieche DR: The puy

hand of drug addiction: A study of the pathogen-

esis.J Bone Joint Surg Am54(3):629-633, 1972

66. Heng MC, Feinberg M, Haberfelde G: Erythema-

tous cutaneous nodules caused by adulterated

cocaine. J Am Acad Dermatol21(3 Pt 1):570-572,

1989

67. Rosen VJ. Cutaneous manifestations of drug

abuse by parenteral injections. Am J Dermatopa-

thol7(1):79-83, 1985

68. Passaro DJ, et al: Wound botulism associated

with black tar heroin among injecting drug users.

JAMA279(11):859-863, 1998

69. Callahan TE, Schecter WP, Horn JK: Necrotizing

soft tissue infection masquerading as cutaneous

abcess following illicit drug injection.Arch Surg133(8):812-817; discussion 817-819, 1998

70. Chen JL, Fullerton KE, Flynn NM: Necrotizing fasci-

itis associated with injection drug use. Clin Infect

Dis33(1):6-15, 2001

71. Haverkos HW, Lange WR: From the Alcohol, Drug

Abuse, and Mental Health Administration. Serious

infections other than human immunodeciency

virus among intravenous drug abusers. J Infect

Dis161(5):894-902, 1990

72. Dunne JH, Johnson WC: Necrotizing skin lesions

in heroin addicts.Arch Dermatol105(4):544-547,

1972 73. Mitchell PA, Pons PT: Wound botulism associated

with black tar heroin and lower extremity celluli-

tis.J Emerg Med20(4):371-375, 2001

74. Abdulla A, Yee L: The clinical spectrum of Clostrid-

ium sordellii bacteraemia: Two case reports and

a review of the literature. J Clin Pathol53(9):709-

712, 2000

75. McGregor JA et al: Maternal deaths associated

with Clostridium sordellii infection.Am J Obstet

Gynecol161(4):987-995, 1989

76. Sinave C et al: Toxic shock syndrome due to

Clostridium sordellii: A dramatic postpartum and

postabortion disease. Clin Infect Dis35(11):1441-

1443, 2002

77. Tuazon CU, Hill R, Sheagren JN: Microbiologic

study of street heroin and injection parapherna-

lia.J Infect Dis129(3):327-329, 1974

78. Bisbe J et al: Disseminated candidiasis in addicts

who use brown heroin: Report of 83 cases and

review. Clin Infect Dis15(6):910-923, 1992

79. Perlman DC et al: Shotgunning as an illicit drug

smoking practice.J Subst Abuse Treat14(1):3-9,

1997

80. Weidman AI, Fellner MJ: Cutaneous manifesta-

tions of heroin and other addictive drugs. Study

and analysis. N Y State J Med71(22):2643-2646,

1971

81. Llibre LM, et al: [Lyells syndrome induced by

heroin contaminants]. Med Clin (Barc)94(20):799,

1990

82. Neugarten J et al: Amyloidosis in subcutaneous

heroin abusers (skin poppers amyloidosis).Am J

Med81(4):635-640, 1986

83. Tossmann P, Boldt S, Tensil MD: The use of drugs

within the techno party scene in European met-

ropolitan cities. Eur Addict Res7(1):2-23, 2001

84. Sulzer D et al: Mechanisms of neurotransmitter

release by amphetamines: A review. Prog Neuro-biol75(6):406-433, 2005

85. Klasser GD, Epstein J: Methamphetamine and

its impact on dental care.J Can Dent Assoc

71(10):759-762, 2005

86. Cook HA, et al: Heterosexual transmission of

community-associated methicillin-resistant

Staphylococcus aureus. Clin Infect Dis44(3):410-

413, 2007

87. Hamamoto DT, Rhodus NL: Methamphetamine

abuse and dentistry. Oral Dis15(1):27-37, 2009

88. Kratol PH, Baberg HT, Dimsdale JE: Self-mutila-

tion and severe self-injurious behavior associatedwith amphetamine psychosis. Gen Hosp Psychia-

try18(2):117-120, 1996

89. Sanchez-Morillas L et al: Systemic dermatitis due

to tetrazepam.J Investig Allergol Clin Immunol

18(5):404-406, 2008

90. Thomas E et al: Acute generalized exanthematous

pustulosis due to tetrazepam.J Investig Allergol

Clin Immunol18(2):119-122, 2008


4/6



91. Amichai B, Grunwald MH: Erythema multiforme

due to clonazepamsupportive evidence from

the macrophage migration inhibition factor test.

Clin Exp Dermatol23(5):206-207, 1998

92. Kiraly CL et al: Eect of androgenic and anabolic

steroids on the sebaceous gland in power ath-

letes. Acta Derm Venereol67(1):36-40, 1987

93. Scott MJ 3rd, Scott AM: Eects of anabolic-andro-

genic steroids on the pilosebaceous unit. Cutis

50(2):113-116, 1992

94. Strauss RH, Liggett MT, Lanese RR: Anabolic

steroid use and perceived eects in ten weight-

trained women athletes.JAMA253(19):2871-2873,

1985

95. Maravelias C et al: Adverse eects of anabolic

steroids in athletes. A constant threat. Toxicol Lett

158(3):167-175, 2005

96. Evans NA. Current concepts in anabolic-andro-

genic steroids.Am J Sports Med32(2):534-542,

2004

97. Scott MJ Jr, Scott MJ 3rd: Dermatologists and

anabolic-androgenic drug abuse. Cutis44(1):30-

35, 1989

98. Hartgens F, Kuipers H: Eects of androgenic-an-

abolic steroids in athletes. Sports Med34(8):513-

554, 2004

99. Al-Ismail K et al: Gluteal mass in a bodybuilder:

Radiological depiction of a complication of ana-

bolic steroid use. Eur Radiol12(6):1366-1369, 2002

100. Weinreb I, Goldblum JR, Rubin BP: Factitial soft

tissue pseudotumor due to injection of anabolicsteroids: A report of 3 cases in 2 patients. Hum

Pathol41(3):452-455, 2010

101. Farkash U, Shabshin N, Pritsch Perry M: Rhabdo-

myolysis of the deltoid muscle in a bodybuilder

using anabolic-androgenic steroids: A case report.

J Athl Train44(1):98-100, 2009

102. Syed SP et al: Anabolic steroids causing growth of

benign tumors: Androgen receptor in angiolipo-

mas.J Am Acad Dermatol57(5):899-900, 2007

103. Lane PR et al: Acute hereditary coproporphyria

induced by the androgenic/anabolic steroid

methandrostenolone (Dianabol).J Am Acad Der-

matol30(2 Pt 2):308-312, 1994

104. Waeber B et al: Skin blood ow and cigarette

smoking: The role of vasopressin. Clin Exp Hyper-

tens A6(10-11):2003-2006, 1984

105. Lefkowitz RJ: Editorial: Smoking, catecholamines,

and the heart. N Engl J Med295(11):615-616, 1976

106. Koch A et al: Acute cardiovascular reactions after

cigarette smoking.Atherosclerosis35(1):67-75,

1980

107. Sarin CL, Austin JC, Nickel WO: Eects of

smoking on digital blood-ow velocity.JAMA

229(10):1327-1328, 1974

108. Shepherd JT: Eect of cigarette-smoking

on blood ow through the hand. Br Med J

2(4738):1007-1010, 1951

109. Benowitz NL et al: Interindividual variability in themetabolism and cardiovascular eects of nico-

tine in man.J Pharmacol Exp Ther221(2):368-372,

1982

110. Aronow WS: Editorial: Smoking, carbon mon-

oxide, and coronary heart disease. Circulation

48(6):1169-1172, 1973

111. Davis JW et al: Eects of tobacco and non-

tobacco cigarette smoking on endothelium and

platelets. Clin Pharmacol Ther37(5):529-533, 1985

112. Dintenfass L. Elevation of blood viscosity, ag-

gregation of red cells, haematocrit values and

brinogen levels with cigarette smokers. Med J

Aust1(20):617-620, 1975

113. Mikhailidis DP, et al: Cigarette smoking inhibits

prostacyclin formation. Lancet2(8350):627-628,

1983

114. Rees TD, Liverett DM, Guy CL: The eect of ciga-

rette smoking on skin-ap survival in the face lift

patient. Plast Reconstr Surg73(6):911-915, 1984

115. Siana JE, Rex S, Gottrup F: The eect of cigarette

smoking on wound healing. Scand J Plast Reconstr

Surg Hand Surg23(3):207-209, 1989

116. Hunt TK, Pai MP: The eect of varying ambient

oxygen tensions on wound metabolism and col-lagen synthesis. Surg Gynecol Obstet135(4):561-

567, 1972

117. Laurent P, Jano A, Kagan HM: Cigarette smoke

blocks cross-linking of elastin in vitro.Am Rev

Respir Dis127(2):189-192, 1983

118. Verghese A et al: The harlequin nail. A marker for

smoking cessation. Chest97(1):236-238, 1990

119. Saietz L: Prevalence of leukokeratosis nicotina

palati among 3,819 danes. Community Dent Oral

Epidemiol3(2):80-85, 1975

120. Pindborg JJ et al: Frequency of Oral Carcinoma,

Leukoplakia, Leukokeratosis, Leukoedema,Submucous Fibrosis, and Lichen Planus in 10,000

Indians in Lucknow, Uttar Pradesh, India; Prelimi-

nary Report.J Dent Res44:61, 1965

121. Farman AG, Van Wyk CW: Leukokeratosis nicotina

glossi-smokers tongue. Int J Oral Surg6(6):340-

347, 1977


5/6

Chapter 105: Cutaneous Manifestations of Drug Abuse 611


122. Axell T, Hedin CA: Epidemiologic study of exces-

sive oral melanin pigmentation with special refer-

ence to the inuence of tobacco habits. Scand J

Dent Res90(6):434-442, 1982

123. Mesa ML et al: Oral warty dyskeratoma. Cutis

33(3):293-294, 296, 1984

124. Winn DM: Smokeless tobacco and cancer:The epidemiologic evidence. CA Cancer J Clin

38(4):236-243, 1988

125. Gupta PC, Mehta FS, Pindborg JJ: Mortality

among reverse chutta smokers in south India. Br

Med J (Clin Res Ed)289(6449):865-866, 1984

126. Gupta PC et al: Mortality experience in relation to

tobacco chewing and smoking habits from a 10-

year follow-up study in Ernakulam District, Kerala.

Int J Epidemiol13(2):184-187, 1984

127. Christen AG: The impact of tobacco use and ces-

sation on oral and dental diseases and conditions.

Am J Med93(1A):25S-31S, 1992

128. Wynder EL, Homann D: Experimental tobacco

carcinogenesis.Adv Cancer Res8:249-453, 1964

129. Carmella SG et al: Mass spectrometric analysis

of tobacco-specic nitrosamine hemoglobin ad-

ducts in snu dippers, smokers, and nonsmokers.

Cancer Res50(17):5438-5445, 1990

130. Thomas WR, Holt PG, Keast D: Recovery of im-

mune system after cigarette smoking. Nature

248(446):358-359, 1974

131. Holt PG, Thomas WR, Keast D: Smoking and im-

munity. Lancet1(7815):1316, 1973

132. Hersey P, Prendergast D, Edwards A: Eectsof cigarette smoking on the immune system.

Follow-up studies in normal subjects after cessa-

tion of smoking. Med J Aust2(9):425-429, 1983

133. Rigel DS et al: Cigarette smoking and malignant

melanoma. Prognostic implications.J Dermatol

Surg Oncol7(11):889-891, 1981

134. Koh HK et al: Cigarette smoking and malignant

melanoma. Prognostic implications. Cancer

53(11):2570-2573, 1984

135. Mills CM et al: Smoking habits in psoriasis: A case

control study. Br J Dermatol127(1):18-21, 1992

136. Naldi L et al: Family history, smoking habits,alcohol consumption and risk of psoriasis. Br J

Dermatol127(3):212-217, 1992

137. Transdermal nicotine for smoking cessation. Six-

month results from two multicenter controlled

clinical trials. Transdermal Nicotine Study Group.

JAMA266(22):3133-3138, 1991

138. Nakamura T: Tobacco dermatitis in Japanese

harvesters. Contact Dermatitis10(5):310, 1984

139. Goncalo M, Couto J, Goncalo S: Allergic contact

dermatitis from Nicotiana tabacum. Contact

Dermatitis22(3):188-189, 1990

140. Singh G: Betel chewers perleche. Br J Dermatol

89(1):98, 1973

141. Zain RB et al: Oral mucosal lesions associated

with betel quid, areca nut and tobacco chewinghabits: Consensus from a workshop held in Kuala

Lumpur, Malaysia, November 2527, 1996.J Oral

Pathol Med28(1):1-4, 1999

142. Daftary DK et al: An oral lichen planus-like lesion

in Indian betel-tobacco chewers. Scand J Dent Res

88(3):244-249, 1980

143. Wei FC et al: Bilateral small radial forearm aps for

the reconstruction of buccal mucosa after surgi-

cal release of submucosal brosis: A new, reliable

approach. Plast Reconstr Surg107(7):1679-1683,

2001

144. Sankaranarayanan R et al: Risk factors for can-

cer of the buccal and labial mucosa in Kerala,

southern India.J Epidemiol Community Health

44(4):286-292, 1990

145. Pindborg JJ et al: Oral submucous brosis as

a precancerous condition. Scand J Dent Res

92(3):224-229, 1984

146. Pindborg JJ: Pathology of oral leukoplakia.Am J

Dermatopathol2(3):277-278, 1980

147. McGurk M, Craig GT: Oral submucous brosis:

Two cases of malignant transformation in Asian

immigrants to the United Kingdom. Br J Oral

Maxillofac Surg22(1):56-64, 1984

148. Su CC et al: Distinctive features of oral cancer

in Changhua County: High incidence, buccal

mucosa preponderance, and a close relation to

betel quid chewing habit.J Formos Med Assoc

106(3):225-233, 2007

149. Bergstein JM et al: Soft tissue abscesses associat-

ed with parenteral drug abuse: Presentation, mi-

crobiology, and treatment.Am Surg61(12):1105-

1108, 1995

150. Gonzalez MH et al: Abscesses of the upper ex-

tremity from drug abuse by injection. J Hand Surg

Am18(5):868-870, 1993

151. Smith DJ Jr et al: Drug injection injuries of theupper extremity.Ann Plast Surg22(1):19-24, 1989

152. Vollum DI: Skin lesions in drug addicts. Br Med J

2(5710):647-650, 1970

153. Funk L, Grover D, de Silva H: Compartment

syndrome of the hand following intra-arterial

injection of heroin.J Hand Surg Br24(3):366-367,

1999


6/6



154. Klabacha ME et al: Inadvertent intraradial arterial

injection of cocaine.Ann Plast Surg13(1):60-62,

1984

155. Pieper B, Templin T: Chronic venous insuciency

in persons with a history of injection drug use.

Res Nurs Health24(5):423-432, 2001

156. Pieper B: A retrospective analysis of venousulcer healing in current and former users of

injected drugs.J Wound Ostomy Continence Nurs

23(6):291-296, 1996

157. Burris S et al: Physician prescribing of sterile injec-

tion equipment to prevent HIV infection: Time for

action.Ann Intern Med133(3):218-226, 2000

158.Administration USSAaMHS: Number of Emergency

Department Visits Associated with Various Drugs

in 2001, 2001, http://thedea.org/statistics.html,

accessed Apr 15, 2010

159.Policy OONDC: http://www.whitehousedrugpoli-

cy.gov, accessed Jun 1, 2010

160. Labcorp I: Drugs of Abuse Reference Guide, 2004,

https://www.labcorp.com/pdf/doa_reference_

guide.pdf, accessed May 1, 2010

Fitzpatricks Derm8e Ref Ch105

Documents

Transcript of Fitzpatricks Derm8e Ref Ch105